Literature DB >> 16311412

Treatment of pituitary tumors: surgery.

Michael Buchfelder1.   

Abstract

Following a century of technical developments and refinements, a variety of standard operation techniques to date are available for the surgical treatment of pituitary tumors. The vast majority of the lesions can be dealt with satisfactorily utilizing transsphenoidal approaches. The goal of surgical treatment is rapid eradication of the tumor mass, decompression of visual pathways, and elimination of hormonal oversecretion while preserving the normal gland and avoiding potential surgical complications. The tumor's size, extension, and configuration and the magnitude of hormonal oversecretion, are the essential factors that decide whether all the goals can be reached. Another important factor is the individual skill and experience of the surgeon. Still, several lesions that are mainly developed outside of the sella require transcranial approaches, of which the pterional and subfrontal routes are the most widely used. With microsurgical techniques and standard approaches, mortality is far below 1% and morbidity is remarkably low. The most favorable surgical results are obtained with microadenomas, which in the MR image are depicted as distinct low intensity lesions. Only recently has the recovery of pituitary function following surgery been convincingly demonstrated. With the extended transsphenoidal approaches, lesions become accessible that previously have been considered contraindications for transsphenoidal surgery. The introduction of new technical gadgets such as neuronavigation, endoscopy, and intraoperative imaging open new avenues and, even more, widen the spectrum of accessible lesions. Indications for surgery, the preoperative workup, surgical techniques, results, limitations, and new technical developments are briefly reviewed in this article.

Entities:  

Mesh:

Year:  2005        PMID: 16311412     DOI: 10.1385/ENDO:28:1:067

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  42 in total

1.  Transsphenoidal surgery for acromegaly in wales: results based on stringent criteria of remission.

Authors:  P De; D A Rees; N Davies; R John; J Neal; R G Mills; J Vafidis; J S Davies; M F Scanlon
Journal:  J Clin Endocrinol Metab       Date:  2003-08       Impact factor: 5.958

2.  Variations on the standard transsphenoidal approach to the sellar region, with emphasis on the extended approaches and parasellar approaches: surgical experience in 105 cases.

Authors:  William T Couldwell; Martin H Weiss; Craig Rabb; James K Liu; Ronald I Apfelbaum; Takanori Fukushima
Journal:  Neurosurgery       Date:  2004-09       Impact factor: 4.654

3.  Effect of octreotide pretreatment on surgical outcome in acromegaly.

Authors:  A Colao; D Ferone; P Cappabianca; M L del Basso De Caro; P Marzullo; A Monticelli; A Alfieri; B Merola; A Calì; E de Divitiis; G Lombardi
Journal:  J Clin Endocrinol Metab       Date:  1997-10       Impact factor: 5.958

4.  Intraoperative magnetic resonance imaging to determine the extent of resection of pituitary macroadenomas during transsphenoidal microsurgery.

Authors:  R J Bohinski; R E Warnick; M F Gaskill-Shipley; M Zuccarello; H R van Loveren; D W Kormos; J M Tew
Journal:  Neurosurgery       Date:  2001-11       Impact factor: 4.654

5.  Surgical management of GH-secreting pituitary adenomas: an outcome study using modern remission criteria.

Authors:  J Kreutzer; M L Vance; M B Lopes; E R Laws
Journal:  J Clin Endocrinol Metab       Date:  2001-09       Impact factor: 5.958

6.  Recovery of hypopituitarism after neurosurgical treatment of pituitary adenomas.

Authors:  S M Webb; M Rigla; A Wägner; B Oliver; F Bartumeus
Journal:  J Clin Endocrinol Metab       Date:  1999-10       Impact factor: 5.958

7.  Significance of "abnormal" nadir growth hormone levels after oral glucose in postoperative patients with acromegaly in remission with normal insulin-like growth factor-I levels.

Authors:  Pamela U Freda; Abu T Nuruzzaman; Carlos M Reyes; Robert E Sundeen; Kalmon D Post
Journal:  J Clin Endocrinol Metab       Date:  2004-02       Impact factor: 5.958

8.  Transsphenoidal microsurgical treatment of Cushing disease: postoperative assessment of surgical efficacy by application of an overnight low-dose dexamethasone suppression test.

Authors:  Joseph C T Chen; Aitun P Amar; SooHo Choi; Peter Singer; Wnluam T Couldwell; Martin H Weiss
Journal:  J Neurosurg       Date:  2003-05       Impact factor: 5.115

9.  Image-guided transsphenoidal surgery for pituitary lesions using Mehrkoordinaten Manipulator (MKM) navigation system.

Authors:  K Kajiwara; T Nishizaki; Y Ohmoto; S Nomura; M Suzuki
Journal:  Minim Invasive Neurosurg       Date:  2003-04

10.  Effectiveness of secondary transnasal surgery in GH-secreting pituitary macroadenomas.

Authors:  Masamichi Kurosaki; Dieter K Luedecke; Takumi Abe
Journal:  Endocr J       Date:  2003-10       Impact factor: 2.349

View more
  9 in total

Review 1.  Intraoperative magnetic resonance imaging during surgery for pituitary adenomas: pros and cons.

Authors:  Michael Buchfelder; Sven-Martin Schlaffer
Journal:  Endocrine       Date:  2012-07-26       Impact factor: 3.633

2.  Multimodal Navigation in Endoscopic Transsphenoidal Resection of Pituitary Tumors Using Image-Based Vascular and Cranial Nerve Segmentation: A Prospective Validation Study.

Authors:  Parviz Dolati; Daniel Eichberg; Alexandra Golby; Amir Zamani; Edward Laws
Journal:  World Neurosurg       Date:  2016-06-11       Impact factor: 2.104

Review 3.  The surgical treatment of acromegaly.

Authors:  Michael Buchfelder; Sven-Martin Schlaffer
Journal:  Pituitary       Date:  2017-02       Impact factor: 4.107

Review 4.  Transcranial surgery for pituitary adenomas.

Authors:  Michael Buchfelder; Juergen Kreutzer
Journal:  Pituitary       Date:  2008       Impact factor: 4.107

5.  [Macular pathology as a cause of visual impairment?].

Authors:  J Matlach; J Nowak; J M Pérez Tejón; W Göbel
Journal:  Ophthalmologe       Date:  2013-08       Impact factor: 1.059

6.  Pituitary surgery for small prolactinomas as an alternative to treatment with dopamine agonists.

Authors:  Muriel Babey; Rahel Sahli; Istvan Vajtai; Robert H Andres; Rolf W Seiler
Journal:  Pituitary       Date:  2011-09       Impact factor: 4.107

7.  Intraoperative handheld optical coherence tomography forward-viewing probe: physical performance and preliminary animal imaging.

Authors:  Cuiru Sun; Kenneth K C Lee; Barry Vuong; Michael D Cusimano; Alexander Brukson; Antonio Mauro; Nigel Munce; Brian K Courtney; Beau A Standish; Victor X D Yang
Journal:  Biomed Opt Express       Date:  2012-05-16       Impact factor: 3.732

8.  Analysis of operative efficacy for giant pituitary adenoma.

Authors:  Shousen Wang; Shun'an Lin; Liangfeng Wei; Lin Zhao; Yinxing Huang
Journal:  BMC Surg       Date:  2014-08-28       Impact factor: 2.102

9.  Approach to the Patient With Treatment-resistant Acromegaly.

Authors:  Eva C Coopmans; Aart J van der Lely; Sebastian J C M M Neggers
Journal:  J Clin Endocrinol Metab       Date:  2022-05-17       Impact factor: 6.134

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.